Transition Programme Helps Patients with Type 1 Diabetes Move to Adult Care

When young adults with type 1 diabetes move from paediatric to adult care they often drop out of medical care and their diabetic control deteriorates. This can lead to increased diabetes-related hospital admissions and acceleration of diabetic complications. Lawson Health Research Institute scientists, Dr Tamara Spaic and Dr Cheril Clarson, have developed a structured transition [...]

By |2017-10-31T10:07:00+00:00October 31st, 2017|Uncategorized|0 Comments

New Type of Diabetes Caused by a Genetic Mutation

Scientific research at the ULB Centre for Diabetes Research and the Erasmus Hospital of the insulin secretion. ULB leads to the identification of a new type of diabetes caused by a mutation in the gene RFX6. The results are published in the scientific journal, Nature Communications. Scientists from the ULB Centre for Diabetes Research and [...]

By |2017-10-31T10:05:16+00:00October 31st, 2017|Uncategorized|0 Comments

Diabetes Researchers Discover Potential New Insulin Sensitizers

A root cause of type 2 diabetes is a condition known as insulin resistance, in which cells stop responding to commands from the hormone that regulates glucose (sugar) storage. Restoring insulin sensitivity can be an effective strategy for preventing and treating diabetes, but the only insulin-sensitizing drugs on the market also stimulate the production of [...]

By |2017-10-31T10:04:10+00:00October 31st, 2017|Uncategorized|0 Comments

New Drug Protects Heart from Cardiac Rupture After Myocardial Infarction

Researchers from Kumamoto University in Japan have revealed that LCZ696 can prevent cardiac rupture and heart failure following acute myocardial infarction, which is one of the causes of chronic heart failure. Heart disease is the leading cause of death in the world, and the majority of those deaths are caused by heart failure and acute [...]

By |2017-10-27T11:40:56+00:00October 27th, 2017|Uncategorized|0 Comments

Heart Failure Therapy Hope as Drug Blocks Deadly Muscle Scarring

A potential treatment to prevent deadly muscle scarring that contributes to chronic heart failure has been uncovered by scientists. The therapy could also prevent scarring of the skeletal muscles we use to move our arms and legs, a cause of long-term disabilities. The treatment works by targeting molecules on the surface of scar-forming cells, called [...]

By |2017-10-27T11:39:23+00:00October 27th, 2017|Uncategorized|0 Comments

New Congenital Heart Disease Genes Uncovered

Approximately one in every 100 babies is born with congenital heart disease (CHD), and CHD remains the leading cause of mortality from birth defects. Although advancements in surgery and care have improved rates of survival for these infants, CHD patients remain at elevated risk for heart complications later in life, other congenital abnormalities and neurodevelopmental [...]

By |2017-10-27T11:37:50+00:00October 27th, 2017|Uncategorized|0 Comments

Tempus ALS is Lightening the Load For Paramedics and First Responders

Remote Diagnostic Technologies Ltd (RDT) has announced the launch of its Tempus ALS monitor and defibrillator. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more. Furthermore, its advanced data collection and sharing capabilities offer a clear pathway for organisations looking to realise the vision of [...]

By |2017-10-24T09:34:03+00:00October 24th, 2017|Uncategorized|0 Comments

New Research System Finds and Targets Vulnerabilities in Lung Cancer Cells

Genetic changes that help lung cancer thrive also make it vulnerable to a promising experimental drug, according to a study led by researchers from Perlmutter Cancer Centre at NYU Langone Health, and published online in Nature Medicine. Specifically, the study found that mutations in the DNA code for the gene KEAP1 help lung adenocarcinoma cells [...]

By |2017-10-20T14:19:35+00:00October 20th, 2017|Uncategorized|0 Comments

Possible New Treatment Pathway for Severe Allergic Asthma

Research has demonstrated that blocking the action of two pro-inflammatory molecules significantly reduces symptoms of allergic asthma in mice, which could lead to the development of a new treatment for people with a severe form of the condition. The findings, which are published in the journal, Clinical Science, show that severe allergic lung inflammation was [...]

By |2017-10-20T14:18:31+00:00October 20th, 2017|Uncategorized|0 Comments

Worms Aid Quest for Asthma Therapies

People with asthma could be helped by a new therapy based on a molecule produced by parasitic worms, new research suggests. Researchers have pinpointed a molecule that dampens their host’s immune response and prevents the allergic reactions that cause asthma attacks. Experts have known for several years that infections with parasitic worms can protect people [...]

By |2017-10-20T14:17:31+00:00October 20th, 2017|Uncategorized|0 Comments
Please Choose

Welcome to!
Are you a Qualified Healthcare Professional or Student?

Access to is solely restricted to qualified healthcare professionals and students within the sector.
Powered by Autience